Moisés Selman is an expert in Pulmonology at Instituto Nacional de Enfermedades Respiratorias (Mexico). As of October 2026, ScienceLeadR ranks Moisés Selman in the top 1% of experts worldwide for Hypersensitivity, Pneumonia and Lung Diseases, Interstitial. Moisés Selman has authored 444 publications, the most recent in 2026, and is an investigator in 7 clinical trials. SLR score: 1,658 (community average: 125). How the SLR is computed.

LeadR Profile

1 658 ScienceLeadR Reputation 1658
Network Map

Pulmonology

Subspecialties: Critical Care - Internal Medicine - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1987 - 2026

Source: PubMed

Instituto Nacional de Enfermedades Respiratorias

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
How experimental models have unlocked hidden mechanisms of hypersensitivity pneumonitis.
PMID 42556849 — cells, genes, respiratory tract diseases, hypersensitivity, antigen-antibody complex, alveolitis, extrinsic allergic
Eur Respir Rev20260
Idiopathic Pulmonary Fibrosis Risk Loci in East Asian Populations Mirror those of European Populations.
PMID 42085270 — idiopathic pulmonary fibrosis, promoter regions, genetic, fibrosis, genome-wide association study, critical care, pulmonary fibrosis, chromosomes
Am J Respir Crit Care Med20260
Imbalanced immune cell network and suboptimal cell activation: signatures associated with disease severity in vaccine-naïve COVID-19 patients.
PMID 41884833 — cytokines, cells, monocytes, vaccines, covid-19, immune system diseases
Front Immunol20260
Age, sex, smoking-specific prevalence and progression in interstitial lung abnormality: patient-level meta-analysis.
PMID 41871447 — lung, respiratory tract diseases, aging, prevalence, sex, smoking
Ann Am Thorac Soc20260
Utility of Z Scores for Defining Progressive Pulmonary Fibrosis in Interstitial Lung Disease.
PMID 41714248 — lung, fibrosis, pulmonary fibrosis, lung diseases, lung diseases, interstitial
Arch Bronconeumol20260

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 2/Phase 3 2
Phase 3 2
N/A 1
Phase 2 1
Phase 4 1

By status:

Completed 5
Active not recruiting 1
Unknown 1

By type:

Interventional 6
Observational 1

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 0
multicentricup10 4

Main Topics

LeadR Networks

Main global connection map